Home Newsfeeds HC Wainwright & Co. Downgrades Humanigen to Neutral

HC Wainwright & Co. Downgrades Humanigen to Neutral

HC Wainwright & Co. analyst Joseph Pantginis downgrades Humanigen (NASDAQ:HGEN) from Buy to Neutral.

byBenzinga Newsdesk

July 13, 2022

1 minute read

HC Wainwright & Co. analyst Joseph Pantginis downgrades Humanigen (NASDAQ:HGEN) from Buy to Neutral.

Unions Take Aim At Apple After Successful Stints At Starbucks, Amazon

By Anusuya Lahiri

September 8, 12:56 PM

Labor groups and investors have filed a shareholder proposal urging Apple Inc (NASDAQ:AAPL) to review its workers’ rights treatment, Reuters reports.…

AAPL

Standard BioTools Announces Full Year 2023 Revenue Of $106M; SomaLogic Expects Q4 2023 Revenue Of ~$23M And FY23 Revenue Of ~$86M

By Benzinga Newsdesk

January 8, 10:06 AM

Standard BioTools Inc. (NASDAQ:LAB) (Standard BioTools or the Company), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, today announced Standard BioTools and SomaLogic, Inc.

LAB

Analyst Ratings

Where Spire Stands With Analysts

By Benzinga Insights

November 18, 10:07 AM

Over the past 3 months, 6 analysts have published their opinion on Spire (NYSE:SR) stock. These analysts are…

Zuckerberg Says Facebook Parent Doing ‘Leading Work’ In Metaverse: ‘On Right Track With These Investments’

By Shivdeep Dhaliwal

October 26, 8:49 PM

Meta Platforms Inc (NASDAQ: META) CEO Mark Zuckerberg is ready to put more of his chips into the fledgling metaverse despite his company’s finance chief anticipating losses of Reality Labs

HC Wainwright & Co. Downgrades Humanigen to Neutral

Related Posts

Unions Take Aim At Apple After Successful Stints At Starbucks, Amazon

Standard BioTools Announces Full Year 2023 Revenue Of $106M; SomaLogic Expects Q4 2023 Revenue Of ~$23M And FY23 Revenue Of ~$86M

Where Spire Stands With Analysts

Zuckerberg Says Facebook Parent Doing ‘Leading Work’ In Metaverse: ‘On Right Track With These Investments’